Published in Mayo Clin Proc on April 01, 2006
The modified National Institutes of Health Stroke Scale: its time has come. Int J Stroke (2009) 1.15
Validity and reliability of a korean version of the national institutes of health stroke scale. J Clin Neurol (2012) 0.94
Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal. Lupus (2009) 0.82
Door-to-door capture of incident and prevalent stroke cases in Durango, Mexico: the Brain Attack Surveillance in Durango Study. Stroke (2011) 0.80
Challenging comparison of stroke scales. J Res Med Sci (2013) 0.79
Functional rehabilitation of upper limb apraxia in poststroke patients: study protocol for a randomized controlled trial. Trials (2015) 0.75
Rehabilitation Profiles of Older Adult Stroke Survivors Admitted to Intermediate Care Units: A Multi-Centre Study. PLoS One (2016) 0.75
Spanish Version of the National Institutes of Health Stroke Scale: Awareness and Use in United States. A Survey Study. J Vasc Interv Neurol (2017) 0.75
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Primary central nervous system vasculitis: analysis of 101 patients. Ann Neurol (2007) 4.68
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health (2013) 4.22
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies. Lancet Neurol (2012) 3.93
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet (2012) 3.40
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04
A genome-wide genotyping study in patients with ischaemic stroke: initial analysis and data release. Lancet Neurol (2007) 2.99
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet (2011) 2.76
Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol (2009) 2.55
The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis (2010) 2.35
High prevalence of stroke symptoms among persons without a diagnosis of stroke or transient ischemic attack in a general population: the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Arch Intern Med (2006) 2.32
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Pharmacoeconomics (2013) 2.21
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMJ (2013) 2.21
Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke (2008) 2.19
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
[CONSORT 2010 Declaration: updated guideline for reporting parallel group randomised trials]. Med Clin (Barc) (2011) 2.10
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg (2012) 1.99
The Ischemic Stroke Genetics Study (ISGS) Protocol. BMC Neurol (2003) 1.98
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Value Health (2013) 1.89
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke (2011) 1.83
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke (2002) 1.82
The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet (2002) 1.82
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Myocardial infarction after carotid stenting and endarterectomy: results from the carotid revascularization endarterectomy versus stenting trial. Circulation (2011) 1.78
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg (2012) 1.74
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J (2012) 1.72
Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg (2004) 1.71
The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ Cardiovasc Genet (2011) 1.71
The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): stenting versus carotid endarterectomy for carotid disease. Stroke (2010) 1.69
Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke (2011) 1.69
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Int J Technol Assess Health Care (2013) 1.66
Self-reported atrial fibrillation and risk of stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke (2011) 1.63
Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial). J Am Coll Cardiol (2011) 1.60
Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet (2011) 1.60
Carotid artery stenting: meeting the recruitment challenge of a clinical trial. Stroke (2005) 1.55
Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis (2003) 1.55
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. Clin Ther (2013) 1.53
Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value Health (2011) 1.51
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke (2013) 1.51
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. J Med Econ (2013) 1.49
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol (2011) 1.47
Diagnosis and invasive management of carotid atherosclerotic stenosis. Mayo Clin Proc (2007) 1.46
Siblings with ischemic stroke study: results of a genome-wide scan for stroke loci. Stroke (2011) 1.45
Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke (2011) 1.45
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement. BMC Med (2013) 1.44
[Decision analysis: diagnostic approach in HIV infection associated chronic diarrhea]. Acta Gastroenterol Latinoam (2005) 1.37
Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma. Ann Neurol (2002) 1.36
Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol (2005) 1.36
Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke (2002) 1.35
The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results. J Vasc Surg (2009) 1.30
Stroke symptoms in individuals reporting no prior stroke or transient ischemic attack are associated with a decrease in indices of mental and physical functioning. Stroke (2007) 1.25
Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence. CNS Drugs (2004) 1.18
Sensitivity and specificity of stroke symptom questions to detect stroke or transient ischemic attack. Neuroepidemiology (2011) 1.16
Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage. Mayo Clin Proc (2004) 1.15
Credentialing of surgeons as interventionalists for carotid artery stenting: experience from the lead-in phase of CREST. J Vasc Surg (2004) 1.14
Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review. J Stroke Cerebrovasc Dis (2007) 1.14
Organizing the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): National Institutes of Health, Health Care Financing Administration, and industry funding. Curr Control Trials Cardiovasc Med (2001) 1.12
Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report--Part VI. Value Health (2009) 1.11
Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke. J Stroke Cerebrovasc Dis (2007) 1.10
Intracranial hemorrhage complicating carotid artery stenting and carotid endarterectomy. Stroke (2011) 1.10
Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research. J Neurosci Methods (2004) 1.08
Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health (2010) 1.08
Incidence of stroke symptoms among adults with chronic kidney disease: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Nephrol Dial Transplant (2011) 1.08
Primary central nervous system vasculitis presenting with intracranial hemorrhage. Arthritis Rheum (2011) 1.07
Approval of the MERCI clot retriever: a critical view. Stroke (2005) 1.04
Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation (2012) 1.03
Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke (2013) 1.02
Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet (2010) 1.02